By Year : Latest  |  All  |   2024  |  2023  |  2022  |  2021  |  2020  |  2019  |  2018  |  2017  |  2016  |  2015  |  2014  |  2013  |  2012

• 24 Dec 2021
• Issuance and offering to the convertible debentures No.10/2021

• 24 Dec 2021
• New shares of JCKH to be traded on December 27, 2021

• 21 Dec 2021
• Issuance and Offering to the Convertible Debentures No.9/2021

• 20 Dec 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 20 Dec 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 20 Dec 2021
• Notification of conversion price calculation of the convertible debentures of JCKH

• 17 Dec 2021
• New shares of JCKH to be traded on December 20, 2021

• 16 Dec 2021
• Notification the exercise of JCKH-W1

• 13 Dec 2021
• Issuance and Offering to the Convertible Debentures No. 8/2021

• 09 Dec 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 09 Dec 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 09 Dec 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 09 Dec 2021
• Notification of conversion price calculation of the convertible debentures of JCKH

• 08 Dec 2021
• New shares of JCKH to be traded on December 9, 2021

• 02 Dec 2021
• Issuance and offering to the convertible debentures No.7/2021

• 01 Dec 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 01 Dec 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 30 Nov 2021
• Notification of conversion price calculation of the convertible debentures of JCKH

• 26 Nov 2021
• Issuance and offering to the convertible debentures No.6/2021

• 22 Nov 2021
• Resolution of the Extraordinary Meeting of Shareholder No. 2/2021

• 22 Nov 2021
• Investment in Other Business

• 18 Nov 2021
• Management Discussion and Analysis Quarter 3 Ending 30 Sep 2021 (Edit)

• 18 Nov 2021
• No Right Adjustment of JCKH-W1

• 17 Nov 2021
• C sign lifted on JCKH's securities

• 16 Nov 2021
• Notice of the amendment of Earnings Per Share (EPS) for three-month period and nine-month periods ending September 30, 2021

• 16 Nov 2021
• Financial Performance Quarter 3 (F45) (Reviewed) (edit EPS.)

• 16 Nov 2021
• Financial Performance Quarter 3 (F45) (Reviewed) (edit EPS.)

• 16 Nov 2021
• Financial Statement Quarter 3/2021 (Reviewed) (Edit EPS.)

• 16 Nov 2021
• Financial Performance Quarter 3 (F45) (Reviewed) (edit)

• 16 Nov 2021
• Financial Performance Quarter 3 (F45) (Reviewed) (edit)

• 16 Nov 2021
• Financial Statement Quarter 3/2021 (Reviewed)

• 16 Nov 2021
• Financial Performance Quarter 3 (F45) (Reviewed)

• 16 Nov 2021
• Management Discussion and Analysis Quarter 3 Ending 30 Sep 2021

• 15 Nov 2021
• Proposal of the 2022 Annual General Shareholder's Meeting Agenda, Names of Director Nominees, and submit the questions in advance.

• 05 Nov 2021
• Publication of the Invitation Letter of Extraordinary General Meeting of Shareholders No.2/2021 on the Company's website

• 28 Oct 2021
• Share allocation unser General Mandate via Private Placement (F53-4-1) (Revised 3) (Revised Template by delete JCKH-W1)

• 28 Oct 2021
• New shares of JCKH to be traded on October 29, 2021

• 27 Oct 2021
• Share allocation unser General Mandate via Private Placement (F53-4-1) (Revised 2)

• 21 Oct 2021
• Report on the results of sale of common shares offered to private placement (F53-5) (No. 5) (Edit)

• 21 Oct 2021
• Report on the results of sale of common shares offered to private placement (F53-5) (No. 2-4) (Edit)

• 21 Oct 2021
• Report on the results of sale of common shares offered to private placement (F53-5) (No. 1) (Edit)

• 20 Oct 2021
• Resolutions of the BOD approving to decrease and increase the registered capital for the offering of shares to RO and PP in General Mandate, the convertible debentures and to convene the EGM No.2/2021 (Revised Date and Time of EGM)

• 20 Oct 2021
• Report on the results of sale of common shares offered to private placement (F53-5) (No. 5)

• 20 Oct 2021
• Report on the results of sale of common shares offered to private placement (F53-5) (No. 1-4)

• 20 Oct 2021
• Share allocation unser General Mandate via Private Placement (F53-4-1) (Revised)

• 19 Oct 2021
• Resolutions of the BOD approving to decrease and increase the registered capital for the offering of shares to RO and PP in General Mandate, the convertible debentures and to convene the EGM No.2/2021

• 19 Oct 2021
• Share allocation unser General Mandate via Private Placement (F53-4-1)

• 18 Oct 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 18 Oct 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 18 Oct 2021
• Report on the results of the Exercise of Convertible Debentures (F53-5) ( Amend number of non conversed Convertible Debentures)

• 18 Oct 2021
• Notification of conversion price calculation of the convertible debentures of JCKH

• 15 Oct 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 15 Oct 2021
• Report on the results of the Exercise of Convertible Debentures (F53-5)

• 15 Oct 2021
• Notification of conversion price calculation of the convertible debentures of JCKH

• 08 Oct 2021
• New shares of JCKH to be traded on October 11, 2021

• 06 Oct 2021
• Report on the results of the Exercise of convertible debentures (F53-5) (Revised Remark)

• 04 Oct 2021
• Issuance and offering to the convertible debentures No.5/2021

• 01 Oct 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 01 Oct 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 01 Oct 2021
• Report on the results of the Exercise of JCKH-W1 (F53-5)

• 30 Sep 2021
• Notification of conversion price calculation of the JCKH Convertible Debentures

• 17 Sep 2021
• Issuance and offering to the convertible debentures No.4/2021

• 15 Sep 2021
• Notification the exercise of JCKH-W1 (Edit)

• 15 Sep 2021
• Notification the exercise of JCKH-W1

• 13 Sep 2021
• New shares of JCKH to be traded on September 14, 2021

• 10 Sep 2021
• Notification on the Calculation in Comparison between the Market Price and the Offering Price of shares to investor via Private Placement

• 09 Sep 2021
• Report on the results of sale of common shares offered to private placement (F53-5)

• 08 Sep 2021
• Report on the results of sale of common shares offered to private placement (F53-5)

• 03 Sep 2021
• Issuance and Offering to the Convertible Debentures No.3/2021

• 30 Aug 2021
• Report on the results of the Exercise of convertible debentures (F53-5) (Edit)

• 30 Aug 2021
• Report on the results of the Exercise of convertible debentures (F53-5) (Edit)

• 30 Aug 2021
• Report on the results of the Exercise of convertible debentures (F53-5) (Edit)

• 30 Aug 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 30 Aug 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 30 Aug 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 27 Aug 2021
• Notification of conversion price calculation of the JCKH Convertible Debentures No. 2/2021

• 27 Aug 2021
• Issuance and offering to the convertible debentures No.2/2021

• 27 Aug 2021
• Notification of conversion price calculation of the JCKH Convertible Debentures No. 1/2021

• 27 Aug 2021
• Share allocation unser General Mandate via Private Placement (F53-4-1) (Revised 2)

• 26 Aug 2021
• Explanation on Guidelines and Progress Report on the Company's Securities which are marked as "C"

• 26 Aug 2021
• Share allocation unser General Mandate via Private Placement (F53-4-1) (Edit the subscription period and payment period)

• 26 Aug 2021
• Share allocation unser General Mandate via Private Placement (F53-4-1) (Edit)

• 25 Aug 2021
• Share allocation unser General Mandate via Private Placement (F53-4-1)

• 19 Aug 2021
• New shares of JCKH to be traded on August 20, 2021

• 18 Aug 2021
• Notification to convene a meeting to report the progress of remedy for the Public Presentation

• 17 Aug 2021
• Financial Statement Quarter 2/2021 (Reviewed)

• 17 Aug 2021
• Financial Performance Quarter 2 (F45) (Reviewed)

• 17 Aug 2021
• Management Discussion and Analysis Quarter 2 Ending 30 Jun 2021

• 11 Aug 2021
• Report on the results of the Exercise of convertible debentures (F53-5) (Edit)

• 11 Aug 2021
• Report on the results of the Exercise of convertible debentures (F53-5) (Edit)

• 10 Aug 2021
• Notification of conversion price calculation

• 10 Aug 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 10 Aug 2021
• Report on the results of the Exercise of convertible debentures (F53-5)

• 04 Aug 2021
• Issuance and offering to the convertible debentures No.01/2021

• 30 Jul 2021
• Report of the Utilization of capital increase

• 30 Jul 2021
• Information Memorandum Description, Condition and Major Characteristics of Warrant to purchase ordinary shares of JCK Hospitality Public Company Limited No. 1 (JCKH-W1)

• 30 Jul 2021
• mai adds new listed securities : JCKH-W1 to be traded on August 2, 2021

• 15 Jul 2021
• Report on the results of the sale of warrants offered to existing common shareholders (F53-5)

• 30 Jun 2021
• New shares of JCKH to be traded on July 1, 2021

• 28 Jun 2021
• Report on the results of sale of common shares offered to private placement (F53-5)

• 25 Jun 2021
• Share allocation unser General Mandate via Private Placement (F53-4-1)

• 15 Jun 2021
• REPORT ON THE EXTRAORDINAY GENERAL MEETING OF SHAREHOLDERS NO.1/2021 RESOLUTIONS

• 28 May 2021
• Publication of the Invitation Letter of Extraordinary General Meeting of Shareholders No.1/2021 on the Company's website

• 27 May 2021
• Explanation on Guidelines and Progress Report on the Company's Securities which are marked as "C"

• 20 May 2021
• Notification to convene a meeting to report the progress of remedy for the Public Presentation (revise the meeting time)

• 18 May 2021
• Notification to convene a meeting to report the progress of remedy for the Public Presentation

• 14 May 2021
• Management Discussion and Analysis Quarter 1 Ending 31 Mar 2021

• 14 May 2021
• Financial Performance Quarter 1 (F45) (Reviewed)

• 14 May 2021
• Financial Statement Quarter 1/2021 (Reviewed)

• 05 May 2021
• Board of Directors' resolutions approving to decrease and increase registered capital for the offering of shares to RO and PP in General Mandate, JCKH-W1, the convertible debentures, and to convene the EGM No.1/2021

• 28 Apr 2021
• New shares of JCKH to be traded on April 29, 2021

• 23 Apr 2021
• Report on the results of sale of common shares offered to private placement (F53-5)

• 20 Apr 2021
• Share allocation under General Mandate via Private Placement

• 16 Apr 2021
• New shares of JCKH to be traded on April 19, 2021

• 09 Apr 2021
• Report on the results of sale of common shares offered to private placement (F53-5)

• 07 Apr 2021
• Share allocation under General Mandate via Private Placement

• 05 Apr 2021
• New shares of JCKH to be traded on April 7, 2021

• 02 Apr 2021
• Report on the results of sale of common shares offered to private placement (F53-5)

• 31 Mar 2021
• Share allocation under General Mandate via Private Placement

• 30 Mar 2021
• The appointment of Executive Director and Joint-Chief Executive Officer

• 26 Mar 2021
• Shareholders meeting's resolution with addtional agenda to appoint the Company's Director.

• 15 Mar 2021
• Publication of the Invitation letter of the 2021 AGM on website

• 11 Mar 2021
• Explanation on Guidelines and Progress Report on the Company's Securities which are marked as "C

• 02 Mar 2021
• Notification to convene a meeting to report the progress of remedy for the Public Presentation

• 01 Mar 2021
• Reporting of the connected transaction regarding to the selling of assets (revised)

• 01 Mar 2021
• Resolutions of the Board of Directors approving to omit dividend payment, to increase the registered capital for the offering to RO and PP in General Mandate, and to convene the 2021 AGM (revised)

• 01 Mar 2021
• Reporting of the connected transaction regarding to the selling of assets

• 01 Mar 2021
• Resolutions of the Board of Directors approving to omit dividend payment, to increase the registered capital for the offering to RO and PP in General Mandate, and to convene the 2021 AGM

• 01 Mar 2021
• Management Discussion and Analysis Yearly Ending 31 Dec 2020

• 01 Mar 2021
• Financial Performance Yearly (F45) (Audited)

• 01 Mar 2021
• Financial Statement Yearly 2020 (Audited)

• 01 Feb 2021
• Report of the Utilization of Capital Increase